Glioblastoma (GBM) is the most aggressive type of brain cancer and its prognosis is generally very poor. This tumor is known for its rapid growth and spread, shocking patients and medical staff alike. Initial symptoms are usually nonspecific and may include headaches, personality changes, nausea, or stroke-like signs. These symptoms often worsen rapidly and may even lead to loss of consciousness.
Glioblastoma accounts for 15% of all brain tumors, and the cause of most cases is unknown, according to research.
Diagnosis of glioblastoma usually requires a combination of computed tomography (CT), magnetic resonance imaging (MRI), and a tissue biopsy. Although many treatment options exist, including surgery, chemotherapy, and radiotherapy, the median survival of patients is usually only 10 to 13 months, and more than 90% of patients will eventually relapse.
Common clinical symptoms of glioblastoma include seizures, headaches, nausea and vomiting, memory loss, and changes in mood or concentration that may occur in patients undergoing treatment. The location of the tumor can affect the types of symptoms that occur. Although symptoms rarely occur, the tumor often grows quickly enough to escape notice until symptoms become apparent.
While the specific causes of glioblastoma are not fully understood, known risk factors include exposure to ionizing radiation and certain genetic syndromes such as neurofibromatosis and Li-Fraumeni syndrome. These risk factors are doubly troubling to some people because glioblastoma often seems to develop without obvious warning signs.
PathophysiologyStudies show that the incidence of glioblastoma is about 3 per 100,000 people each year.
Glioblastomas arise from astrocytes, cells in the brain that support neurons. The tumors usually form in the white matter of the brain, grow rapidly, and can become quite large before causing symptoms. Once cancerous, these cells can easily spread along existing pathways within the brain and can affect areas that were not previously involved.
Glioblastomas often present as ring-enhancing lesions on MRI; this feature is not specific, as other lesions such as abscesses or metastatic tumors may also demonstrate similar findings. Definitive diagnosis usually requires stereotactic biopsy or tumor resection, and the correct diagnosis can only be made after pathological confirmation.
The treatment of glioblastoma is complex and faces multiple challenges, including resistance of tumor cells to traditional therapies. Surgery is the first stage of treatment. By removing the tumor, the patient's brain pressure can be reduced and the frequency of epileptic seizures can be reduced accordingly. Radiotherapy and chemotherapy after surgery can effectively improve the survival rate; however, for glioblastoma, the risk of recurrence is still very high.
Overall, although current treatment options for glioblastoma have significantly improved survival, patients still face many challenges. Even though science and technology continue to advance, we still need to continue exploring and thinking about how to more effectively deal with possible future challenges for this highly aggressive tumor.